Hemostasis is the body's process for stopping bleeding after a blood vessel is injured while still keeping blood flowing elsewhere. It is essential for survival because even small vessel damage must be sealed quickly and accurately. This process depends on blood vessels, platelets, and clotting proteins working in a coordinated sequence.
In medicine, understanding hemostasis helps explain bleeding disorders, thrombosis, and the effects of drugs like aspirin, clopidogrel, heparin, and warfarin.
Primary hemostasis begins when platelets adhere to exposed subendothelial collagen, mainly through von Willebrand factor, and then activate and aggregate to form a temporary platelet plug. Secondary hemostasis strengthens that plug through the coagulation cascade, which generates thrombin and converts fibrinogen into fibrin. The fibrin mesh stabilizes the clot so it can resist blood flow and support vessel repair.
Defects in primary hemostasis often cause mucosal bleeding and petechiae, while defects in secondary hemostasis more often cause deep tissue bleeding and hematomas.
Understanding Hemostasis
The response starts even before a clot forms. Smooth muscle in the injured vessel wall contracts, making the opening narrower. This reduces blood loss for a short time.
The healthy lining of nearby blood vessels normally prevents platelets from sticking. It releases substances such as nitric oxide and prostacyclin that keep platelets quiet. Injury removes this protective surface at one small spot.
Platelets then change from smooth discs into spiky cells. They release chemical signals, including ADP and thromboxane, which call in more platelets. This local control is important because a clot spreading through an uninjured vessel could block blood supply to tissue.
Clotting proteins circulate in blood as inactive forms. They are activated in a chain, with each step helping speed up the next one. Calcium ions and phospholipid surfaces supplied by activated platelets help several of these reactions occur efficiently.
Thrombin has a central role beyond making fibrin. It activates more clotting factors and stimulates platelets, creating a strong burst of clot formation at the wound. Factor thirteen then links fibrin strands together.
This cross linking makes the mesh more durable. Red blood cells and white blood cells can become trapped in this mesh, giving a mature clot its bulk.
The body must later remove the clot once repair has begun. Platelets pull on fibrin strands, a process called clot retraction. This draws the wound edges closer and squeezes out fluid called serum.
At the same time, the vessel lining gradually activates plasmin, an enzyme that cuts fibrin apart. This process is called fibrinolysis. A breakdown product called D dimer can be measured in blood.
A raised D dimer does not prove that a harmful clot is present, since surgery, infection, pregnancy, and injury can raise it too. It is most useful when interpreted with symptoms and other tests.
Patterns of bleeding help doctors locate a possible problem. Frequent nosebleeds, gum bleeding, heavy menstrual bleeding, or tiny red skin spots often point toward low platelet number or poor platelet function. Joint bleeds and large muscle bruises suggest a shortage of certain clotting factors.
Hemophilia is a classic example and can cause prolonged deep bleeding after trauma. Liver disease matters because the liver makes many clotting proteins. Vitamin K is needed to produce several of them, so poor absorption or some medicines can increase bleeding risk.
In laboratory work, a prolonged PT may reflect problems involving factor seven or the common pathway. A prolonged aPTT can occur with deficiencies in factors eight, nine, eleven, or twelve, though results always need clinical context.
Key Facts
- Primary hemostasis: platelet adhesion + platelet activation + platelet aggregation = temporary platelet plug.
- Platelet adhesion is mediated by vWF binding exposed collagen and platelet GPIb receptors.
- Platelet aggregation is mediated by GPIIb/IIIa receptors binding fibrinogen between adjacent platelets.
- Secondary hemostasis generates thrombin, and thrombin converts fibrinogen to fibrin: fibrinogen -> fibrin.
- Coagulation pathways converge at factor X activation: Xa + Va converts prothrombin to thrombin.
- PT assesses the extrinsic and common pathways, while aPTT assesses the intrinsic and common pathways.
Vocabulary
- Hemostasis
- Hemostasis is the regulated process that stops bleeding at a site of vascular injury.
- von Willebrand factor
- von Willebrand factor is a plasma protein that helps platelets stick to exposed subendothelial collagen.
- Platelet plug
- A platelet plug is the temporary mass of adhered and aggregated platelets formed during primary hemostasis.
- Thrombin
- Thrombin is a coagulation enzyme that converts fibrinogen into fibrin and amplifies clot formation.
- Fibrin
- Fibrin is the insoluble protein mesh that stabilizes the platelet plug during secondary hemostasis.
Common Mistakes to Avoid
- Confusing primary and secondary hemostasis, which is wrong because platelets mainly form the initial plug while coagulation factors mainly stabilize it with fibrin.
- Thinking platelets bind directly to intact endothelium, which is wrong because normal endothelium is antithrombotic and platelet adhesion occurs after endothelial disruption exposes collagen and vWF.
- Assuming PT and aPTT measure the same pathway, which is wrong because PT mainly reflects the extrinsic pathway and aPTT mainly reflects the intrinsic pathway.
- Believing all bleeding disorders look the same, which is wrong because platelet disorders usually cause petechiae and mucosal bleeding, while coagulation factor defects often cause deep bleeding and hemarthroses.
Practice Questions
- 1 A patient has a platelet count of 40,000 per microliter after chemotherapy. Which part of hemostasis is most directly impaired, and what type of bleeding pattern would you expect?
- 2 A patient with hemophilia A has reduced factor VIII activity. Does this primarily affect primary or secondary hemostasis, and which lab test is most likely prolonged: PT or aPTT?
- 3 A patient takes aspirin daily and develops easy bruising and prolonged bleeding from gum injury, but fibrin formation is otherwise normal. Explain why the initial clot is weak even though the coagulation cascade can still occur.